Shifting dermatology market strategies from cosmetics to moisturizers and sanitizers treatments in <scp>COVID</scp> ‐19 era
Notice bibliographique
Résumé
Dermatologic TherapyVolume 33, Issue 4 e13806 Letter Shifting dermatology market strategies from cosmetics to moisturizers and sanitizers treatments in COVID-19 era Robert A. Schwartz, Robert A. Schwartz orcid.org/0000-0003-3036-3825 Department of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USASearch for more papers by this authorSwetalina Pradhan, Swetalina Pradhan Department of Dermatology and Venereology, All India Institute of Medical Sciences, Patna, IndiaSearch for more papers by this authorHassan Galadari, Hassan Galadari Department of Dermatology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab EmiratesSearch for more papers by this authorTorello Lotti, Torello Lotti orcid.org/0000-0003-0840-1936 Department of Dermatology, University of Studies Guglielmo Marconi, Rome, ItalySearch for more papers by this authorAseem Sharma, Aseem Sharma orcid.org/0000-0001-5873-227X Dermatology Unit, Skin Saga Centre for Dermatology, Mumbai, IndiaSearch for more papers by this authorMohamad Goldust, Corresponding Author Mohamad Goldust [email protected] orcid.org/0000-0002-9615-1246 Department of Dermatology, University of Rome G. Marconi, Rome, Italy Department of Dermatology, University Hospital Basel, Basel, Switzerland Correspondence Mohamad Goldust, Department of Dermatology, University Hospital Basel, Basel, Switzerland. Email: [email protected]Search for more papers by this author Robert A. Schwartz, Robert A. Schwartz orcid.org/0000-0003-3036-3825 Department of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USASearch for more papers by this authorSwetalina Pradhan, Swetalina Pradhan Department of Dermatology and Venereology, All India Institute of Medical Sciences, Patna, IndiaSearch for more papers by this authorHassan Galadari, Hassan Galadari Department of Dermatology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab EmiratesSearch for more papers by this authorTorello Lotti, Torello Lotti orcid.org/0000-0003-0840-1936 Department of Dermatology, University of Studies Guglielmo Marconi, Rome, ItalySearch for more papers by this authorAseem Sharma, Aseem Sharma orcid.org/0000-0001-5873-227X Dermatology Unit, Skin Saga Centre for Dermatology, Mumbai, IndiaSearch for more papers by this authorMohamad Goldust, Corresponding Author Mohamad Goldust [email protected] orcid.org/0000-0002-9615-1246 Department of Dermatology, University of Rome G. Marconi, Rome, Italy Department of Dermatology, University Hospital Basel, Basel, Switzerland Correspondence Mohamad Goldust, Department of Dermatology, University Hospital Basel, Basel, Switzerland. Email: [email protected]Search for more papers by this author First published: 12 June 2020 https://doi.org/10.1111/dth.13806Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Rudnicka L, Gupta M, Kassir M, et al. Priorities for global health community in COVID-19 pandemic. Dermatol Ther. 2020;e13361. https://doi.org/10.1111/dth.13361. 10.1111/dth.13361 PubMedWeb of Science®Google Scholar 2Goldust M, Shivakumar S, Kroumpouzos G, Murrell DF, Mueller SM, Navarini AA. Where do we stand as dermatologists in combat with COVID-19. Dermatol Ther. 2020. https://doi.org/10.1111/dth.13638. 10.1111/dth.13638 Web of Science®Google Scholar 3Murrell DF, Arora G, Rudnicka L, et al. Will teledermatology be the silver lining during and after COVID-19? Dermatol Ther. 2020. https://doi.org/10.1111/dth.13538. Web of Science®Google Scholar 4Sadoughifar R, Goldust M, Kroumpouzos G, Szepietowski JC, Lotti T, Sandhu S. Dermatologic treatments in the era of the COVID-19 pandemics—data and hypothesis. Dermatol Ther. 2020;e13562. https://doi.org/10.1111/dth.13562. PubMedWeb of Science®Google Scholar 5Arora G, Kroumpouzos G, Kassir M, et al. Solidarity and transparency against the COVID-19 pandemic. Dermatol Ther. 2020;edth13359. https://doi.org/10.1111/dth.13359. 10.1111/dth.13359 PubMedWeb of Science®Google Scholar 6Gupta M, Abdelmaksoud A, Jafferany M, Lotti T, Sadoughifar R, Goldust M. COVID-19 and economy. Dermatol Ther. 2020;e13329. https://doi.org/10.1111/dth.13329. 10.1111/dth.13329 PubMedWeb of Science®Google Scholar 7Sharma A, Fölster-Holst R, Kassir M, et al. The effect of quarantine and isolation for COVID-19 in general population and dermatologic treatments. Dermatol Ther. 2020;e13398. https://doi.org/10.1111/dth.13398. PubMedWeb of Science®Google Scholar 8 CDC. COVID-19: U.S. at a Glance. 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Google Scholar 9Bogdanov I, Darlenski R, Hristakieva E, Manuelyan K. The rash that presents as a vesiculobullous eruption. Clin Dermatol. 2020; 38(1): 19-34. 10.1016/j.clindermatol.2019.10.012 PubMedWeb of Science®Google Scholar 10Gupta MK, Lipner SR. Personal protective equipment recommendations based on COVID-19 route of transmission. J Am Acad Dermatol. 2020; e45-e46. https://doi.org/10.1016/j.jaad.2020.04.068. PubMedWeb of Science®Google Scholar Citing Literature ReferencesRelatedInformation
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,002 | 0,007 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,001 | 0,000 |
| Études des sciences et des technologies | 0,002 | 0,002 |
| Communication savante | 0,003 | 0,003 |
| Science ouverte | 0,001 | 0,002 |
| Intégrité de la recherche | 0,006 | 0,008 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,038 | 0,011 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».